Skip to main content
. 2017 May 7;8(29):47389–47399. doi: 10.18632/oncotarget.17650

Figure 2. Analysis of ITGB1 expression in NSCLC.

Figure 2

(A) Relative expression levels of ITGB1 in different cancer cell lines vs. normal controls from the GEO dataset (GSE41445). (B) ITGB1 was indicated as a potential cancer driver in the Candidate Cancer Gene Database (CCGD), involved in liver, colorectal, pancreatic and nervous system cancer. (C) Relative expression levels of ITGB1 in a microarray profiles data (GSE67061-GPL6480) from GEO database, which including 8 cases of immortalized human bronchial epithelial cell lines (BEC) and 69 cases of lung squamous cell carcinoma tissues (LSCC). (D) ITGB1 expression levels in cancer vs. paired adjacent non-tumor tissue (n = 27). (E) ITGB1 expression in tumor samples (n = 134) and adjacent non-tumor lung tissue (n = 27) were analyzed using qRT-PCR assay.